Print

Galena Biopharma  (GALE) Reports Third Quarter 2012 Financial Results  
11/13/2012 8:30:46 AM

LAKE OSWEGO, Ore., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today reported its financial results for the quarter ended September 30, 2012 and provided a business update.
//-->